Key facts
- Wavelet (Monitoring Equipment)’s last known valuation is $19.0M (Apr 2026).
- It has raised $7.0M; the latest was Seed Round ($7.0M) in Apr 2026.
- Notable investors include MedTech Innovator, National Institutes of Health, Aegis Ventures, National Science Foundation Innovation Corps Program.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Wavelet (Monitoring Equipment)
- ·The full record, as it builds
Funding rounds
No funding rounds for Wavelet (Monitoring Equipment) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Wavelet (Monitoring Equipment)
Developer of monitoring devices designed to assess fetal brain development. The company uses electroencephalography (EEG)-based real-time signal acquisition, machine learning-driven pattern recognition, and visual analytics, enabling obstetric care providers to obtain non-invasive insights into prenatal neurological health and support more informed clinical decision-making.
- Sector
- Healthcare
- HQ
- New Haven, CT, United States
- Founded
- 2024
- Employees
- 8
- Website
- wavelet.co/
- Ownership
- Privately Held (backing)
Wavelet (Monitoring Equipment) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Wavelet (Monitoring Equipment) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Wavelet (Monitoring Equipment) in its N-PORT filings yet. We sweep new filings monthly.